Connor, Clark & Lunn Investment Management (CC&L)’s Aquestive Therapeutics AQST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-47,817
| Closed | -$124K | – | 1423 |
|
|
2024
Q2 | $124K | Sell |
47,817
-171,582
| -78% | -$446K | ﹤0.01% | 1299 |
|
|
2024
Q1 | $935K | Sell |
219,399
-42,193
| -16% | -$180K | ﹤0.01% | 907 |
|
|
2023
Q4 | $528K | Buy |
261,592
+13,764
| +6% | +$27.8K | ﹤0.01% | 1031 |
|
|
2023
Q3 | $379K | Buy |
247,828
+30,898
| +14% | +$47.3K | ﹤0.01% | 1086 |
|
|
2023
Q2 | $358K | Buy |
+216,930
| New | +$358K | ﹤0.01% | 1071 |
|
|
2022
Q2 | – | Sell |
-31,396
| Closed | -$82K | – | 1033 |
|
|
2022
Q1 | $82K | Buy |
31,396
+3,014
| +11% | +$7.87K | ﹤0.01% | 984 |
|
|
2021
Q4 | $110K | Buy |
+28,382
| New | +$110K | ﹤0.01% | 1028 |
|